Intestinal microbiota in liver diseases: current state of the problem
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 3
Abstract
The article presents analysis of the recent literature data, the results of experimental and clinical studies on role of participation the intestinal microbiota in the pathogenesis of various liver diseases: viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, primary sclerosing cholangitis, liver cirrhosis and hepatocellular carcinoma. Particular attention is paid to increasing intestinal permeability, which creates conditions for bacterial translocation, activation of the systemic inflammatory response, increased hyperdynamic blood flow and deterioration of the functional state of the liver. As a striking example of the effect of intestinal microbiota on the state of the liver, data on small intestinal bacterial overgrowth syndrome (SIBR) are presented. There was a high incidence of SIBR in chronic liver diseases, a relationship between increased intestinal permeability and severity of impaired liver function, development and severity of hepatic encephalopathy, and the likelihood of spontaneous bacterial peritonitis. Role of intestinal microbiota in the development of bacterial complications in liver cirrhosis, especially spontaneous bacterial peritonitis, is discussed. It is shown that intestinal dysbiosis is involved in dysregulation of the cell death/regeneration balance that underlies carcinogenesis. It is concluded that it is reasonable to include drugs correcting the composition of intestinal microbiota in therapy of a number of liver diseases. The advantages of rifaximin administration have been outlined in the improvement of liver functional state at non-alcoholic steatohepatitis, hepatic encephalopathy by means of correcting the composition of the intestinal microbiome.
Authors and Affiliations
N. B. Gubergrits, N. V. Byelyayeva, E. V. Berezhna, A. Ye. Klochkov, P. G. Fomenko, A. V. Tsys
Keywords
Related Articles
- EP ID EP616019
- DOI 10.30978/MG-2019-3-79
- Views 145
- Downloads 0
The role of intestinal microbiome in the progression of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is considered an important and economically significant public health problem, its progression can result in development of cirrhosis and hepatocellular carcinoma. Over the past...
MicroRNAs: properties and role in the development and progression of non-alcoholic fatty liver disease
MicroRNAs (miRNAs) are the small non-coding RNAs that regulate multiple physiological and pathological processes through the modulation of gene expression at the post-transcriptional level. The role of miRNAs has been pr...
The peculiarities of the effects of herbal preparations on the functional state of intestine during the treatment of patients with constipation
The analysis has been performed for the literature data as regards the medicinal herbs Operculina turpethum, Indian Gooseberry (Emblica officinalis), Cassia fistula, common licorice (Glycyrrhiza glabra), which are the co...
The lactase gene polymorphism and the course of chronic pancreatitis in patients with essential hypertension
Objective — to determine the polymorphism of the 13910 C/T marker of the LCТ gene associated with the combined course of chronic pancreatitis (ChP) and hypertensive disease (HD). Materials and methods. The examinations i...
The role of thyroid hormones in the formation mechanisms of motor-secretory disorders in patients with gastroesophageal reflux disease with concomitant autoimmune thyroiditis
Objective — to study the role of thyroid hormones in the formation of motor-secretory disorders with the comorbid course of gastroesophageal reflux disease (GERD) and autoimmune thyroiditis (AIT). Materials and methods....